Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
NOT FOR HUMAN CONSUMPTION - NOT FDA APPROVED
SS31, also known as Elamipretide, is a mitochondria targeted peptide designed to support mitochondrial function by interacting with cardiolipin, a phospholipid found within the inner mitochondrial membrane.
It is being investigated for its potential to improve cellular energy production, reduce oxidative stress and support overall mitochondrial health.
As mitochondria play a central role in energy metabolism and cellular function, SS31 has become an important focus of research into healthy ageing, physical performance and diseases associated with mitochondrial dysfunction.
Research
SS31 has been evaluated in numerous laboratory studies, animal models and human clinical trials across a range of conditions linked to impaired mitochondrial function.
Research has demonstrated improvements in mitochondrial efficiency, reduced oxidative damage and enhanced cellular energy production, with studies investigating its potential in cardiovascular disease, kidney disease, age related muscle decline and rare mitochondrial disorders.
Clinical research remains ongoing to further define its therapeutic potential and long term safety across different patient populations.
Bacteriostatic water is included.
NOT FOR HUMAN CONSUMPTION - NOT FDA APPROVED
SS31, also known as Elamipretide, is a mitochondria targeted peptide designed to support mitochondrial function by interacting with cardiolipin, a phospholipid found within the inner mitochondrial membrane.
It is being investigated for its potential to improve cellular energy production, reduce oxidative stress and support overall mitochondrial health.
As mitochondria play a central role in energy metabolism and cellular function, SS31 has become an important focus of research into healthy ageing, physical performance and diseases associated with mitochondrial dysfunction.
Research
SS31 has been evaluated in numerous laboratory studies, animal models and human clinical trials across a range of conditions linked to impaired mitochondrial function.
Research has demonstrated improvements in mitochondrial efficiency, reduced oxidative damage and enhanced cellular energy production, with studies investigating its potential in cardiovascular disease, kidney disease, age related muscle decline and rare mitochondrial disorders.
Clinical research remains ongoing to further define its therapeutic potential and long term safety across different patient populations.
Bacteriostatic water is included.